Should you buy CTXR stock?
Last updated:
Based on market data through , StockInvest.us rates Citius Pharmaceuticals Inc (CTXR) as a Buy Candidate with a technical score of 3.47 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Buy signal since
- Price since signal Up 18.98%
- 3-month trend forecast Down 6.25%
- Highly efficient cash conversion (100% FCF/OCF ratio)
- Lower volatility than the market (beta 0.98)
- Established player in the Healthcare sector
Red day on Monday for Citius Pharmaceuticals Inc stock after losing 0.777%
(Market data through Aug 10, 2026)
The Citius Pharmaceuticals Inc stock price fell by -0.777% on the last day (Monday, 10th Aug 2026) from $0.682 to $0.677. During the last trading day the stock fluctuated 3.38% from a day low at $0.674 to a day high of $0.697. The price has risen in 6 of the last 10 days and is up by 31% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -118 thousand shares and in total, 314 thousand shares were bought and sold for approximately $212.34 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -6.25% during the next 3 months and, with a 90% probability hold a price between $0.439 and $0.730 at the end of this 3-month period.
CTXR Signals & Forecast
The Citius Pharmaceuticals Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.653 and $0.574. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, August 06, 2026, and so far it has risen 5.45%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Support, Risk & Stop-loss for Citius Pharmaceuticals Inc stock
On the downside, the stock finds support just below today's level from accumulated volume at $0.632 and $0.546. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Citius Pharmaceuticals Inc finds support just below today's level at $0.632. If this is broken, then the next support from accumulated volume will be at $0.546 and $0.527.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0228 between high and low, or 3.38%. For the last week the stock has had daily average volatility of 13.91%.
Our recommended stop-loss: $0.651 (-3.84%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 2 days ago.)
Trading Expectations (CTXR) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Citius Pharmaceuticals Inc to open at $0.683, and during the day (based on 14 day Average True Range), to move between $0.643 and $0.711, which gives a possible trading interval of +/-$0.0679 (+/-10.56%) up or down from last closing price. If Citius Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 10.56% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $0.697 (2.95%) than the support at $0.632 (6.65%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Citius Pharmaceuticals Inc stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.
Current score:
3.470
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $0.683 ( 0.83%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
CTXR Performance
Trading levels for CTXR
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.705 | 4.19% |
| R2 | 0.697 | 2.91% |
| R1 | 0.691 | 2.11% |
| Price | 0.677 | |
| S1 | 0.674 | -0.459% |
| S2 | 0.669 | -1.25% |
| S3 | 0.660 | -2.54% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.781 | 15.35% |
| R2 | 0.720 | 6.35% |
| R1 | 0.697 | 2.95% |
| Price | 0.677 | |
| S1 | 0.632 | -6.65% |
| S2 | 0.546 | -19.42% |
| S3 | 0.527 | -22.16% |
FAQ
Click here for our free guide on how to buy Citius Pharmaceuticals Inc Stock.
Buy CTXR